首页> 美国卫生研究院文献>SAGE Choice >Routine Adoption of TIMP2 and IGFBP7 Biomarkers in Cardiac Surgery for Early Identification of Acute Kidney Injury
【2h】

Routine Adoption of TIMP2 and IGFBP7 Biomarkers in Cardiac Surgery for Early Identification of Acute Kidney Injury

机译:在心脏外科手术中常规采用TIMP2和IGFBP7生物标志物以早期识别急性肾损伤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background and purposeAcute Kidney Injury (AKI) is a severe complication affecting many hospitalized patients after cardiac surgery, with negative impacts on short- and long-term clinical outcomes and on healthcare costs. Recently, clinical interest has been aimed at defining and classifying AKI, identifying risk factors and developing diagnostic strategies to identify patients at risk early on. Achieving an early and accurate diagnosis of AKI is a crucial issue, because prevention and timely detection may help to prevent negative clinical outcomes and avoid AKI-associated costs. In this retrospective study, we evaluate the NephroCheck Test as a diagnostic tool for early detection of AKI in a high-risk population of patients undergoing cardiac surgery at the San Bortolo Hospital of Vicenza.
机译:背景与目的急性肾损伤(AKI)是一种严重的并发症,在心脏外科手术后影响许多住院患者,对短期和长期临床结局以及医疗费用产生负面影响。近来,临床兴趣已经集中在定义和分类AKI,识别危险因素和开发诊断策略以尽早识别处于危险中的患者。尽早进行准确的AKI诊断是至关重要的问题,因为预防和及时发现可能有助于防止不良的临床结果并避免与AKI相关的费用。在这项回顾性研究中,我们评估了NephroCheck测试,作为在维琴察州San Bortolo医院接受心脏手术的高危患者中早期检测AKI的诊断工具。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号